2021 ICD-10-CM Code D61.09
Other constitutional aplastic anemia
Valid for Submission
D61.09 is a billable diagnosis code used to specify a medical diagnosis of other constitutional aplastic anemia. The code D61.09 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D61.09 might also be used to specify conditions or terms like autosomal dominant aplasia and myelodysplasia, complete deafness, congenital deafness, constitutional aplastic anemia, constitutional aplastic anemia , constitutional aplastic anemia, etc.
ICD-10: | D61.09 |
Short Description: | Other constitutional aplastic anemia |
Long Description: | Other constitutional aplastic anemia |
Code Classification
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D61.09:
Inclusion Terms
Inclusion TermsThese terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Fanconi's anemia
- Pancytopenia with malformations
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D61.09 are found in the index:
- - Aleukia
- - hemorrhagica - D61.9
- - congenital - D61.09
- - hemorrhagica - D61.9
- - Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) - D64.9
- - aplastic - D61.9
- - congenital - D61.09
- - aregenerative
- - congenital - D61.09
- - chronica congenita aregenerativa - D61.09
- - congenital - P61.4
- - aplastic - D61.09
- - Fanconi's (congenital pancytopenia) - D61.09
- - aplastic - D61.9
- - Disease, diseased - See Also: Syndrome;
- - Fanconi's (congenital pancytopenia) - D61.09
- - Erythroblastophthisis - D61.09
- - Erythrogenesis imperfecta - D61.09
- - Fanconi's anemia (congenital pancytopenia) - D61.09
- - Pancytopenia (acquired) - D61.818
- - with
- - malformations - D61.09
- - congenital - D61.09
- - with
- - Panhematopenia - D61.9
- - congenital - D61.09
- - constitutional - D61.09
- - Panhemocytopenia - D61.9
- - congenital - D61.09
- - constitutional - D61.09
- - Panmyelopathy, familial, constitutional - D61.09
- - Panmyelophthisis - D61.82
- - congenital - D61.09
- - Syndrome - See Also: Disease;
- - Fanconi's (anemia) (congenital pancytopenia) - D61.09
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Autosomal dominant aplasia and myelodysplasia
- Complete deafness
- Congenital deafness
- Constitutional aplastic anemia
- Constitutional aplastic anemia
- Constitutional aplastic anemia
- Constitutional aplastic anemia
- Constitutional aplastic anemia
- Constitutional aplastic anemia with malformation
- Estren-Dameshek anemia
- Fanconi's anemia
- Hereditary isolated aplastic anemia
- Pancytopenia with developmental delay syndrome
- WT limb blood syndrome
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code D61.09 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2021.
- 808 - MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC - Relative Weight: 2.1779
- 809 - MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC - Relative Weight: 1.2217
- 810 - MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC - Relative Weight: 0.9607
Convert D61.09 to ICD-9 Code
- 284.09 - Const aplastc anemia NEC
Information for Patients
Aplastic Anemia
Aplastic anemia is a rare but serious blood disorder. If you have it, your bone marrow doesn't make enough new blood cells. There are different types, including Fanconi anemia. Causes include
- Toxic substances, such as pesticides, arsenic, and benzene
- Radiation therapy and chemotherapy for cancer
- Certain medicines
- Infections such as hepatitis, Epstein-Barr virus, or HIV
- Autoimmune disorders
- Certain inherited conditions
- Pregnancy
In many people, the cause is unknown.
Symptoms include fatigue, weakness, dizziness, and shortness of breath. It can cause heart problems such as an irregular heartbeat, an enlarged heart, and heart failure. You may also have frequent infections and bleeding.
Your doctor will diagnose aplastic anemia based on your medical and family histories, a physical exam, and test results. Once your doctor knows the cause and severity of the condition, he or she can create a treatment plan for you. Treatments include blood transfusions, blood and marrow stem cell transplants, and medicines.
NIH: National Heart, Lung, and Blood Institute
- Aplastic anemia (Medical Encyclopedia)
- Fanconi anemia (Medical Encyclopedia)
[Learn More]
Fanconi anemia Fanconi anemia is a condition that affects many parts of the body. People with this condition may have bone marrow failure, physical abnormalities, organ defects, and an increased risk of certain cancers.The major function of bone marrow is to produce new blood cells. These include red blood cells, which carry oxygen to the body's tissues; white blood cells, which fight infections; and platelets, which are necessary for normal blood clotting. Approximately 90 percent of people with Fanconi anemia have impaired bone marrow function that leads to a decrease in the production of all blood cells (aplastic anemia). Affected individuals experience extreme tiredness (fatigue) due to low numbers of red blood cells (anemia), frequent infections due to low numbers of white blood cells (neutropenia), and clotting problems due to low numbers of platelets (thrombocytopenia). People with Fanconi anemia may also develop myelodysplastic syndrome, a condition in which immature blood cells fail to develop normally.More than half of people with Fanconi anemia have physical abnormalities. These abnormalities can involve irregular skin coloring such as unusually light-colored skin (hypopigmentation) or café-au-lait spots, which are flat patches on the skin that are darker than the surrounding area. Other possible symptoms of Fanconi anemia include malformed thumbs or forearms and other skeletal problems including short stature; malformed or absent kidneys and other defects of the urinary tract; gastrointestinal abnormalities; heart defects; eye abnormalities such as small or abnormally shaped eyes; and malformed ears and hearing loss. People with this condition may have abnormal genitalia or malformations of the reproductive system. As a result, most affected males and about half of affected females cannot have biological children (are infertile). Additional signs and symptoms can include abnormalities of the brain and spinal cord (central nervous system), including increased fluid in the center of the brain (hydrocephalus) or an unusually small head size (microcephaly).Individuals with Fanconi anemia have an increased risk of developing a cancer of blood-forming cells in the bone marrow called acute myeloid leukemia (AML) or tumors of the head, neck, skin, gastrointestinal system, or genital tract. The likelihood of developing one of these cancers in people with Fanconi anemia is between 10 and 30 percent.
[Learn More]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)